Aadi Bioscience Inc
AADI
Get informed when a big investor buys or sells
+ FollowMarket Cap$94.89M
Close$
Share Statistics
| Market cap | $94.89 Million |
|---|---|
| Enterprise Value | $60.10 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.03 |
| Beta | 0.34 |
| Outstanding Shares | 69,236,945 |
Return
| Return on Equity | -99.68% |
|---|---|
| Return on Assets | -91.02% |
| Return on Invested Capital | -105.62% |
Valuation & Multiples
| P/E Ratio | -2.64 |
|---|---|
| PEG | 2.03 |
| Price to Sales | - |
| Price to Book Ratio | 2.05 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.49 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
March 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 47.65%▲ 5.99% |
|---|---|
| Total Invested | $79.25M▲ 45.83% |
| Investors Holding | 47▲ 8.00% |
ESG Score
No data
About Aadi Bioscience Inc
12 employeesAerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing compounds that activate Tie2 for indications in which the Company believes that activation of Tie2 may have therapeutic potential. The Company's lead compo...